Dr Medbeat Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
- Revenue Growth 44.07%
- Profit Growth -56.94%
- Ebitda -36.30%
- Net Worth -160.42%
- Total Assets -25.93%
About Dr Medbeat Remedies
Dr Medbeat Remedies Private Limited (DMRPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 January 2021 (Four years and one month 18 days old ). Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Sushanta Roy, Sanjay Datta, and Tamali Palodhi serve as directors at the Company.
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909WB2021PTC242389
- Company No.
242389
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Dr Medbeat Remedies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushanta Roy  | Director | 06-Jan-2021 | Current |
| Sanjay Datta | Director | 06-Jan-2021 | Current |
| Tamali Palodhi | Director | 06-Jan-2021 | Current |
Financial Performance of Dr Medbeat Remedies.
Dr Medbeat Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.07% increase. The company also saw a substantial fall in profitability, with a 56.94% decrease in profit. The company's net worth observed a substantial decline by a decrease of 160.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Medbeat Remedies?
Unlock access to Dr Medbeat Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Oct 2023 | Indian Bank | ₹1.00 Cr | Open |
How Many Employees Work at Dr Medbeat Remedies?
Dr Medbeat Remedies has a workforce of 41 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Medbeat Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Medbeat Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.